Phibro Animal Health Corp(PAHC) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | 15.03 | EPS (ttm) | 2.43 | Insider Own | 48.62% | Shs Outstand | 21.1M | Perf Week | -8.34% |
| Market Cap | 1.49B | Forward P/E | 9.5 | EPS next Y | 9.98% | Insider Trans | -0.68% | Shs Float | 20.9M | Perf Month | 7.37% |
| Enterprise Value | 2.19B | PEG | 1.07 | EPS next Q | 0.77 | Inst Own | 52.65% | Short Float | 5.91% | Perf Quarter | 17.35% |
| Income | 0.10B | P/S | 0.98 | EPS this Y | 8.74% | Inst Trans | -0.84% | Short Ratio | 4.97 | Perf Half Y | -26.92% |
| Sales | 1.52B | P/B | 3.85 | EPS next 5Y | 8.87% | ROA | 6.97% | Short Interest | 1.23M | Perf YTD | -2.06% |
| Book/sh | 9.5 | P/C | 18.12 | EPS past 3/5Y | 44.61% 12.64% | ROE | 29.72% | 52W High | -39.1% ($60.08) | Perf Year | -11.15% |
| Cash/sh | 2.02 | P/FCF | 150.52 | Sales past 3/5Y | 15.79% 12.74% | ROIC | 8.76% | 52W Low | 29.52% ($28.25) | Perf 3Y | 191.09% |
| Dividend Est. | $0.48 (1.31%) | EV/EBITDA | 8.69 | EPS Y/Y TTM | 106.4% | Gross Margin | 33.61% | Volatility(W/M) | 4.07% 4.06% | Perf 5Y | 61.9% |
| Dividend TTM | 0.48 | EV/Sales | 1.44 | Sales Y/Y TTM | 17.12% | Oper. Margin | 13.23% | ATR (14) | 1.47 | Perf 10Y | 41.66% |
| Dividend Ex-Date | 2026/9/2 | Quick Ratio | 1.27 | EPS Q/Q | 25.12% | Profit Margin | 6.57% | RSI (14) | 51.07 | Recom | 2.8 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.96 | Sales Q/Q | 4.77% | SMA20 | 0.31% ($36.48) | Beta | 0.42 | Target Price | $44 |
| Payout | 19.72% | Debt/Eq | 2.05 | Earnings | 2026/8/26 | SMA50 | 4.05% ($35.17) | Rel Volume | 0.7 | Prev Close | $36.8 |
| Employees | 2605 | LT Debt/Eq | 1.95 | EPS/Sales Surpr. | 19.25% 4.07% | SMA200 | -12.43% ($41.78) | Avg Volume(3M) | 0.25M | Price | $36.59 |
| IPO | 2014/4/11 | Option/Short | Yes/Yes | Trades | 5774 | Volume | 174,046 | Change | -0.57% |
Company
PAHC is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🐄 Phibro Animal Health (PAHC) is a global animal health company that develops, manufactures, and sells animal pharmaceuticals and mineral nutritional supplements for livestock and companion animals. The company primarily focuses on products for food-producing animals such as poultry, swine, cattle, and aquaculture, and has diversified its business to include mineral nutrition and industrial specialty chemical products.
Over the past 1 year, roughly in the middle
39% below its 1-year high.
PAHC makes money exceptionally well
Strong earnings and excellent financial health
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +8.7% this year.
Tap to view numbers
The price looks about right
Trading at 15.0 times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 3 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have paid off
Would have changed by +191.1% if bought 5 years ago.
Tap to view numbers
The dividend is on the small side
Pays 1.31% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 52.6%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
SAWS 0.02%
RZG 0.01%
XPH 0.01%
PILL 0.01%
ROSC 0.01%It ranks #4 in the industry
Based on market cap of $1B.
PAHC $1B PER 15.0
TAK $58B PER -
TEVA $42B PER 61.1
HLN $41B PER 19.0
FAQ
What kind of company is PAHC?
PAHC belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is the market cap of PAHC?
The market cap of PAHC is approximately $1.5B, ranking 2,332 within its sector.
Does PAHC pay dividends?
PAHC has a dividend yield of approximately 1.31%, with an annual dividend of $0.48.
What is the P/E ratio of PAHC?
PAHC has a P/E ratio of approximately 15.0x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for PAHC?
PAHC has recorded a 52-week high of $60.08 and a low of $28.25.
